UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
July 31, 2006
Date of report (Date of earliest event reported)
MedicalCV, Inc.
(Exact name of registrant as specified in its charter)
Minnesota | 000-33295 | 41-1717208 |
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
9725 South Robert Trail
Inver Grove Heights, Minnesota 55077
(Address of principal executive offices, including zip code)
(651) 452-3000
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2):
oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 5.02 DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS
(b) We previously reported John H. Jungbauer’s intention to resign as our principal financial officer and principal accounting officer. Mr. Jungbauer’s resignation from those positions was effective at the close of business on July 31, 2006.
(c) We previously reported Eapen Chacko’s intention to assume the roles of principal financial officer and principal accounting officer upon Mr. Jungbauer’s resignation from those positions. Mr. Chacko, who has served as our Vice President, Finance and Chief Financial Officer since June 21, 2006, assumed the roles of principal financial officer and principal accounting officer effective at the close of business on July 31, 2006. We previously reported the remaining information required by Item 5.02(c) of Form 8-K regarding Mr. Chacko in our Current Report on Form 8-K filed June 5, 2006.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| MedicalCV, Inc. | |
| | | |
Date: August 2, 2006 | By: | /s/ Eapen Chacko | |
| | Eapen Chacko | |
| | Vice President, Finance and Chief Financial Officer | |
3
